HomeNewsIndiaShortage of COVID-19 vaccine: CMs seek PM Modi's attention, ask for extension of eligibility criteria of vaccination

Shortage of COVID-19 vaccine: CMs seek PM Modi's attention, ask for extension of eligibility criteria of vaccination

Issues of vaccine hesitancy and vaccine wastage were also discussed during the meeting of PM Narendra Modi and chief ministers.

April 09, 2021 / 11:18 IST
Story continues below Advertisement
During the meeting, the CMs gave feedback about the COVID-19 situation in their respective states, said a statement issued by the prime minister’s office. ()Image: Screenshot/@narendramodi)
During the meeting, the CMs gave feedback about the COVID-19 situation in their respective states, said a statement issued by the prime minister’s office. ()Image: Screenshot/@narendramodi)

In an interaction with Prime Minister Narendra Modi to discuss the COVID-19 situation and the ongoing vaccination drive, the chief ministers sought attention towards shortage of coronavirus vaccines and demanded permission to vaccinate younger people.

Currently, the inoculations are limited to those aged over 45 year in the country.

Story continues below Advertisement

During the meeting, the CMs gave feedback about the COVID-19 situation in their respective states, said a statement issued by the prime minister’s office. They said that the timely initiation of vaccination drive is resulting in saving lakhs of lives. Issues of vaccine hesitancy and vaccine wastage were also discussed, said the statement.

Talking to PM Modi, Odisha Chief Minister Naveen Patnaik drew his attention to the shortage of the COVID-19 vaccine in the state. Noting that half of Odisha’s vaccination centres having halted activities for want of Covishield, he requested the prime minister to ensure that the state gets to stock up doses 10 days in advance for the vaccination drive to run smoothly.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show